Marco De Vivo

PhD

Visit Website

Genoa, Italy

Istituto Italiano di Tecnologia

About

Research Lab Director, Molecular Modeling & Drug Discovery Lab

Istituto Italiano di Tecnologia

Genoa, Italy

scientific

Projects

Specimen

Planning

CDC42 RHOJ Interaction Inhibitors for the Treatment of Neurofibromatosis…

Neurofibromatosis type 2 (NF2) tumors can cause significant hearing loss and current therapies can accelerate this loss through the impact of side effects and non compliance. Using cell lines provided by the Children’s Brain Tumor Network, researchers are testing new treatments to address this issue.

…

Anand Ganesan

University of California, Irvine

Irvine, CA, USA